JP7710206B2 - 創傷治癒薬 - Google Patents

創傷治癒薬

Info

Publication number
JP7710206B2
JP7710206B2 JP2019571114A JP2019571114A JP7710206B2 JP 7710206 B2 JP7710206 B2 JP 7710206B2 JP 2019571114 A JP2019571114 A JP 2019571114A JP 2019571114 A JP2019571114 A JP 2019571114A JP 7710206 B2 JP7710206 B2 JP 7710206B2
Authority
JP
Japan
Prior art keywords
hydrogel
deoxyribose
sugar
wound
paragraph
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2019571114A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020510701A5 (enExample
JP2020510701A (ja
Inventor
ヤール、ムハンマド
マクニール、シェイラ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Comsats Institute of Information Technology
Original Assignee
Comsats Institute of Information Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Comsats Institute of Information Technology filed Critical Comsats Institute of Information Technology
Publication of JP2020510701A publication Critical patent/JP2020510701A/ja
Publication of JP2020510701A5 publication Critical patent/JP2020510701A5/ja
Priority to JP2023043133A priority Critical patent/JP2023078307A/ja
Application granted granted Critical
Publication of JP7710206B2 publication Critical patent/JP7710206B2/ja
Priority to JP2025138878A priority patent/JP2025172803A/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/244—Lanthanides; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/38—Silver; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/731—Cellulose; Quaternized cellulose derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0052—Mixtures of macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/008—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Materials Engineering (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Materials For Medical Uses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
JP2019571114A 2017-03-07 2018-03-07 創傷治癒薬 Active JP7710206B2 (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2023043133A JP2023078307A (ja) 2017-03-07 2023-03-17 創傷治癒薬
JP2025138878A JP2025172803A (ja) 2017-03-07 2025-08-22 創傷治癒薬

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1703656.7A GB201703656D0 (en) 2017-03-07 2017-03-07 Wound healing medicament
GB1703656.7 2017-03-07
PCT/GB2018/050579 WO2018162900A1 (en) 2017-03-07 2018-03-07 Wound healing medicament

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023043133A Division JP2023078307A (ja) 2017-03-07 2023-03-17 創傷治癒薬

Publications (3)

Publication Number Publication Date
JP2020510701A JP2020510701A (ja) 2020-04-09
JP2020510701A5 JP2020510701A5 (enExample) 2021-04-22
JP7710206B2 true JP7710206B2 (ja) 2025-07-18

Family

ID=58543858

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2019571114A Active JP7710206B2 (ja) 2017-03-07 2018-03-07 創傷治癒薬
JP2023043133A Pending JP2023078307A (ja) 2017-03-07 2023-03-17 創傷治癒薬
JP2025138878A Pending JP2025172803A (ja) 2017-03-07 2025-08-22 創傷治癒薬

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2023043133A Pending JP2023078307A (ja) 2017-03-07 2023-03-17 創傷治癒薬
JP2025138878A Pending JP2025172803A (ja) 2017-03-07 2025-08-22 創傷治癒薬

Country Status (9)

Country Link
US (3) US20210154206A1 (enExample)
EP (2) EP3681509B1 (enExample)
JP (3) JP7710206B2 (enExample)
CN (1) CN110612106A (enExample)
CA (1) CA3055467A1 (enExample)
ES (1) ES2955029T3 (enExample)
GB (1) GB201703656D0 (enExample)
SG (1) SG11201908060PA (enExample)
WO (1) WO2018162900A1 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9884027B2 (en) 2012-01-12 2018-02-06 Nanofiber Solutions, Inc. Nanofiber scaffolds for biological structures
GB201703656D0 (en) 2017-03-07 2017-04-19 Univ Sheffield Wound healing medicament
EP3870125A4 (en) * 2018-10-24 2022-08-03 Somnio Global Holdings, LLC FUNCTIONAL WOUND HEALING DRESSINGS
JP2022513442A (ja) 2018-12-11 2022-02-08 ナノファイバー ソリューションズ、エルエルシー 電界紡糸繊維を使用した慢性創傷の治療方法
CA3182868A1 (en) * 2020-07-22 2022-01-27 John K. Jackson Blended polyvinyl alcohol drug delivery systems
WO2022076117A1 (en) * 2020-09-08 2022-04-14 Protein Genomics Inc. Biomimetic wound healing devices and related methods of treating diabetic wounds
CN115770322A (zh) * 2022-11-29 2023-03-10 江南大学 一种免疫调节水凝胶及其制备方法和应用
CN115944774A (zh) * 2022-12-04 2023-04-11 吉林大学 一种迷迭香酸-壳聚糖-聚乙烯醇水凝胶敷料及其制备方法和应用
US20250288716A1 (en) * 2022-12-30 2025-09-18 Süleyman Demirel Üniversitesi Idari Ve Mali Isler Daire Baskanligi Genel Sekreterlik Development of egg white based nanofiber treatment material
CN116459383B (zh) * 2023-02-28 2024-07-19 兰州大学 一种用于促进糖尿病伤口愈合的铈基mof水凝胶及其制备方法和应用
CN118831037B (zh) * 2024-06-28 2025-02-25 广东适配生物科技有限公司 一种负载微球和纳米酶的多功能微针及其制备方法和应用

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2854243A1 (fr) 2003-04-24 2004-10-29 Oreal Procede de determination d'etats pre-alopeciques et/ou d'atteintes cutanees au moyen d'un marqueur predictif: hif-1(hypoxia inducible factor-1)
WO2007129618A1 (ja) 2006-05-08 2007-11-15 National University Corporation Kagawa University 好中球の活性化および遊走因子の抑制剤およびその利用
JP2013521230A (ja) 2010-02-25 2013-06-10 アルコン リサーチ， リミテッド 角膜創傷治癒を促進する方法
WO2014165253A1 (en) 2013-03-12 2014-10-09 Nbip, Llc Compositions and methods for preventing infection of a wound and for advancing the healing process

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1232318B (it) * 1989-09-07 1992-01-28 Crinos Industria Farmaco Composizioni ad uso topico contenenti acidi nucleici depolimerizzati per la cosmesi della pelle e del corpo.
US5177065A (en) * 1990-12-26 1993-01-05 Silvetti Sr Anthony N Monosaccharide containing wound healing preparation
US7090745B2 (en) * 2002-09-13 2006-08-15 University Of Pittsburgh Method for increasing the strength of a cellulosic product
EP1773240B1 (en) * 2004-06-11 2019-11-20 Trustees of the Tufts College Silk-based drug delivery system
FR2879443B1 (fr) * 2004-12-21 2007-07-13 Jean Noel Thorel Utilisation d'une base nutritive complexe dans le domaine cosmetique, en particulier capillaire
GB0813541D0 (en) * 2008-07-24 2008-08-27 Brightwake Ltd Honey wound dressing
US20110104279A1 (en) * 2009-11-04 2011-05-05 Marraccini Philip A Healing powder and method of use thereof
GB2509439A (en) * 2011-10-28 2014-07-02 Afexa Life Sciences Inc Use of a ginseng extract to prevent and treat alopecia areata
GB201703656D0 (en) 2017-03-07 2017-04-19 Univ Sheffield Wound healing medicament

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2854243A1 (fr) 2003-04-24 2004-10-29 Oreal Procede de determination d'etats pre-alopeciques et/ou d'atteintes cutanees au moyen d'un marqueur predictif: hif-1(hypoxia inducible factor-1)
WO2007129618A1 (ja) 2006-05-08 2007-11-15 National University Corporation Kagawa University 好中球の活性化および遊走因子の抑制剤およびその利用
JP2013521230A (ja) 2010-02-25 2013-06-10 アルコン リサーチ， リミテッド 角膜創傷治癒を促進する方法
WO2014165253A1 (en) 2013-03-12 2014-10-09 Nbip, Llc Compositions and methods for preventing infection of a wound and for advancing the healing process

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
医学書院 医学大辞典, 株式会社 医学書院, 2003年03月01日, 発行日, 第１４１７頁（「繊維芽細胞」）
医学書院 医学大辞典, 株式会社 医学書院, 2003年03月01日, 発行日, 第１７０１頁（「デオキシリボース」）
日本血栓止血学会誌, 2006, 発行日, １７（５）, 第５９２頁
日本血栓止血学会誌, 2007, 発行日, １８（５）, 第５２６頁

Also Published As

Publication number Publication date
EP4233911A2 (en) 2023-08-30
US20250099486A1 (en) 2025-03-27
BR112019018596A2 (pt) 2020-04-07
US20250025474A1 (en) 2025-01-23
EP3681509A1 (en) 2020-07-22
SG11201908060PA (en) 2019-09-27
JP2020510701A (ja) 2020-04-09
CA3055467A1 (en) 2018-09-13
GB201703656D0 (en) 2017-04-19
EP3681509C0 (en) 2023-06-07
EP3681509B1 (en) 2023-06-07
US20210154206A1 (en) 2021-05-27
ES2955029T3 (es) 2023-11-28
JP2025172803A (ja) 2025-11-26
EP4233911A3 (en) 2023-09-20
JP2023078307A (ja) 2023-06-06
WO2018162900A1 (en) 2018-09-13
CN110612106A (zh) 2019-12-24

Similar Documents

Publication Publication Date Title
JP7710206B2 (ja) 創傷治癒薬
JP7486404B2 (ja) 羊膜粉末ならびに創傷治癒および組織工学構築物におけるその使用
Mohanty et al. A human epidermal growth factor-curcumin bandage bioconjugate loaded with mesenchymal stem cell for in vivo diabetic wound healing
Wong et al. Engineered pullulan–collagen composite dermal hydrogels improve early cutaneous wound healing
Bondioli et al. Development and evaluation of a decellularized membrane from human dermis
Wu et al. RETRACTED ARTICLE: Decellularized scaffolds containing hyaluronic acid and EGF for promoting the recovery of skin wounds
Yar et al. Deoxy-sugar releasing biodegradable hydrogels promote angiogenesis and stimulate wound healing
Konop et al. The role of allogenic keratin‐derived dressing in wound healing in a mouse model
JP2016504932A (ja) 非哺乳動物組織からの脱細胞化生体材料
Arasteh et al. Efficient wound healing using a synthetic nanofibrous bilayer skin substitute in murine model
Shakya et al. Bubaline cholecyst derived extracellular matrix for reconstruction of full thickness skin wounds in rats
CN121013736A (zh) 组合物及使用所述组合物的脂肪移植
BR112019018596B1 (pt) Uso de um açúcar d-desoxirribose para promover a cicatrização de feridas, bem como material de matriz biocompatível, hidrogel e uso destes para promover a cicatrização de feridas e curativos para feridas
WO2025061827A1 (en) Kit for the reconstitution of a cell-free biomedical device for use in regenerative medicine, biomedical device thus reconstituted and related synthesis process
CN119971129A (zh) 一种促进糖尿病伤口愈合的药物递送系统及其制备方法和应用
Shakya et al. Research Article Bubaline Cholecyst Derived Extracellular Matrix for Reconstruction of Full Thickness Skin Wounds in Rats

Legal Events

Date Code Title Description
RD01 Notification of change of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7426

Effective date: 20200304

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20200304

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20210304

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20210304

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20220408

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20220707

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220825

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20220826

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20221117

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230317

C60 Trial request (containing other claim documents, opposition documents)

Free format text: JAPANESE INTERMEDIATE CODE: C60

Effective date: 20230317

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20230317

C11 Written invitation by the commissioner to file amendments

Free format text: JAPANESE INTERMEDIATE CODE: C11

Effective date: 20230407

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20230509

A912 Re-examination (zenchi) completed and case transferred to appeal board

Free format text: JAPANESE INTERMEDIATE CODE: A912

Effective date: 20230526

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250130

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20250630

R150 Certificate of patent or registration of utility model

Ref document number: 7710206

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150